HB 1435 Maryland House of Delegates · 2026 Regular Session

Health Insurance - Required Coverage - Hormone-Related Care

HB 1435 requires Maryland health insurance companies, nonprofit health plans, and health maintenance organizations to cover hormone-related care for perimenopausal and menopausal symptoms. This includes hormone therapy, hormone-modulating medications, related lab testing, and clinical visits, with coverage not denied based on diagnosis (like menopause symptoms), age, or prior treatment history. The bill prohibits extra approval steps, stricter limitations, or higher costs for this care compared to similar treatments. It also mandates that coverage decisions follow evidence-based guidelines and the treating provider’s clinical judgment, ensuring timely access to care.
Bill status in committee 1 of 4 stages cleared
Introduction
Feb 2026
Committee Review
Floor Vote
Governor
Introduced Feb 13, 2026 Last action Mar 13, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
5
Key actions
0
Committee
1
Feb 13, 2026
Committee
First Reading Health
lower
11 primary · 0 co-sponsors

Sponsors